Self‐monitoring and self‐management of oral anticoagulation

CJ Heneghan, JM Garcia-Alamino… - Cochrane Database …, 2016 - cochranelibrary.com
Background The introduction of point‐of‐care devices for the management of patients on
oral anticoagulation allows self‐testing by the patient at home. Patients who self‐test can …

Impact of rivaroxaban on point-of-care assays

P Fontana, L Alberio, A Angelillo-Scherrer, LM Asmis… - Thrombosis research, 2017 - Elsevier
Background Point-of-care testing (POCT) is regularly used to assess haemostasis in various
clinical settings. The impact of rivaroxaban on those POCT is still elusive. We aimed to study …

Anticoagulation Management in Patients with Valve Replacement.

D Saksena, S Muralidharan, YK Mishra… - The Journal of the …, 2018 - europepmc.org
Anticoagulation Management in Patients with Valve Replacement. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

Faktor-faktor yang berhubungan dengan self management pada pasien hemodialisis di Kota Bekasi

PA Astuti - Healthcare Nursing Journal, 2019 - journal.umtas.ac.id
Penatalaksanaan gagal ginjal terminal membutuhkan modifikasi gaya hidup pasien dalam
mengatur diet, membatasi cairan, rejimen medikasi, perawatan akses vaskuler dan …

A qualitative study evaluating provider perceptions of implementing warfarin patient self‐management in the United States healthcare system

AS Wilson, S Slager, AE Jones… - Journal of the …, 2023 - Wiley Online Library
Background Despite consensus guideline recommendations, the use of warfarin patient self‐
management (PSM) in the US healthcare system remains small in comparison to European …

Predicting recurrent venous thromboembolism in patients with deep-vein thrombosis: development and internal validation of a potential new prediction model (Continu …

M Nagler, SMJ Van Kuijk, H Ten Cate… - Frontiers in …, 2021 - frontiersin.org
Background: Previous prediction models for recurrent thromboembolism (VTE) are often
complicated to apply and have not been implemented widely. Aim: To develop and internally …

Home management of warfarin treatment through a real-time supervised telemedicine solution: a randomized controlled trial

CL Brasen, JS Madsen, T Parkner… - Telemedicine and e …, 2019 - liebertpub.com
Background: Many patients are undergoing oral anticoagulation treatment with vitamin K
antagonists, which necessitates measuring international normalized ratio (INR) several …

A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity

MCJ Roex, L Hageman, SAJ Veld… - Blood, The Journal …, 2020 - ashpublications.org
Tumor-associated antigens (TAAs) are monomorphic self-antigens that are proposed as
targets for immunotherapeutic approaches to treat malignancies. We investigated whether T …

Sex differences in treatment quality of self-managed oral anticoagulant therapy: 6,900 patient-years of follow-up

H Nilsson, EL Grove, TB Larsen, PB Nielsen, F Skjøth… - PloS one, 2014 - journals.plos.org
Background Patient-self-management (PSM) of oral anticoagulant therapy with vitamin K
antagonists has demonstrated efficacy in randomized, controlled trials. However, the …

Rivaroxaban in patients with mechanical heart valves: a pilot study

E Roost, A Weber, L Alberio, L Englberger… - Thrombosis research, 2020 - Elsevier
Background Patients with mechanical heart valves are still not eligible for treatment with
direct oral anticoagulants (DOAC). We aimed to conduct a proof-of-principle study …